Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Ampyra (Fampyra)
Pathogenic implications of iron accumulation in multiple sclerosis.
Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS).
Subclinical myocardial dysfunction in multiple sclerosis patients remotely treated with mitoxantrone: evidence of persistent diastolic dysfunction.
Some recent advances in multiple sclerosis.
Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.
Relationship between neuromuscular and perceived fatigue and locomotor performance in patients with multiple sclerosis.
Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Extavia Prescribing Information
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
Cost-effectiveness analysis of peginterferon beta-1a compared with interferon beta-1a and glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis in the United States.
Dimethyl Fumarate Protects Brain From Damage Produced by Intracerebral Hemorrhage by Mechanism Involving Nrf2.
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
AB Science confirms the filing for the Marketing Authorization Application to the European Medicines Agency of masitinib in the treatment of pancreatic cancer
Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS.
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
Three-Month Test-Retest Reliability of Center of Pressure Motion During Standing Balance in Individuals with Multiple Sclerosis.
MicroRNAs: The Role in Autoimmune Inflammation.
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.
Optical Coherence Tomography: A Potential Noninvasive Follow-up Tool in Multiple Sclerosis.
Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.
Is No Evidence of Disease Activity a Realistic Goal for Patients With Multiple Sclerosis?

Pages